Optase Solution/ Drops
Product Images NDC 72972-007

7 FDA label images from Scope Health Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Optase (NDC 72972-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Scope Health Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Optase Intense 30x Pil-page 1 (Optase Us Intense Patient Leaflet 30 X1a 2026 (p) Page 1)

Optase Intense 30x Pil-page 1 (Optase Us Intense   Patient Leaflet 30 X1a 2026 (p) Page 1)
Instructions for use of Optase Dry Eye Intense Drops solution in single-dose containers are shown. The text explains the product relieves dry eye symptoms, contains glycerin as a humectant, and is free from alcohol, preservatives, and animal-derived ingredients. Nine steps guide users on opening the aluminum pouch, handling single-dose containers, administering drops to the eye, and discarding used containers. Accompanying illustrations correspond with the steps for application.*
FDA Label Image

Optase Intense 30x Pil-page 2 (Optase Us Intense Patient Leaflet 30 X1a 2026 (p) Page 2)

Optase Intense 30x Pil-page 2 (Optase Us Intense   Patient Leaflet 30 X1a 2026 (p) Page 2)
The image shows a drug facts and precaution panel for Optase Dry Eye Intense Drops. It includes usage warnings such as external use only, avoiding contamination, proper disposal of single-dose containers, and storage instructions. It lists the active ingredient glycerin 0.2% and inactive ingredients. Manufacturer information for Scope Health Inc., New York, is provided, along with contact info and brand trademark details.*
FDA Label Image

Optase Intense 5x Pil-page 1 (Optase Us Intense Patient Leaflet 5 X1a 2026 (p) Page 1)

Optase Intense 5x Pil-page 1 (Optase Us Intense   Patient Leaflet 5 X1a 2026 (p) Page 1)
The image shows an instruction leaflet for Optase Dry Eye INTENSE Drops, containing glycerin as the active ingredient. It provides detailed usage instructions illustrated with five diagrams guiding users on how to open the single-dose containers and apply the drops safely for dry eye relief. The text also explains the product's purpose and characteristics, including the absence of alcohol, preservatives, and compatibility with contact lenses.*
FDA Label Image

Optase Intense 5x Pil-page 2 (Optase Us Intense Patient Leaflet 5 X1a 2026 (p) Page 2)

Optase Intense 5x Pil-page 2 (Optase Us Intense   Patient Leaflet 5 X1a 2026 (p) Page 2)
This image shows the precautions, warnings, and composition information for OPTASE Dry Eye Intense Drops, an ophthalmic solution containing glycerin 0.2% as the active ingredient. It includes safety instructions for use, storage conditions, and a contact address for Scope Health Inc.*
FDA Label Image

Optase Intense Sdu X30 Box (Optase Us Intense Sdu X30 Box 2026 (p))

Optase Intense Sdu X30 Box (Optase Us Intense Sdu X30 Box 2026 (p))
Packaging label for Optase Dry Eye Intense Drops, a lubricant eye drop solution containing glycerin at 2 mg/mL concentration. The label indicates the product is preservative-free and provided in 30 single-dose containers of 0.01 fl oz (0.5 mL) each. The labeler is Scope Health Inc. The label includes drug facts, usage instructions, warnings, and a depiction of a purple eye symbolizing the hydration effect for dry eye relief.*
FDA Label Image

Optase Intense Sdu X5 Sample Box (Optase Us Intense Sample Sdu X5 Box 2026 (p))

Optase Intense Sdu X5 Sample Box (Optase Us Intense  Sample Sdu X5 Box 2026 (p))
Packaging label for Optase Intense Drops, an ophthalmic solution with glycerin 2 mg/mL, designed for dry eye relief. The carton indicates preservative-free lubricant eye drops in 5 single-dose containers, 0.01 fl oz (0.5 mL) each. Labeler is Scope Health Inc, with contact lens compatibility and intended for intense dry eye symptoms. Includes Drug Facts and directions for use.*
FDA Label Image

Optase Intense Immediate Label (Optase Us Intense Sdu Foil Pack 2026 (p))

Optase Intense Immediate Label (Optase Us Intense  Sdu Foil Pack 2026 (p))
Label for Optase Dry Eye Intense Drops ophthalmic solution by Scope Health Inc. The product contains single-dose containers, five in total, each with 0.01 fl oz (0.5 mL) of solution. The label features the brand name prominently and an icon of an eye, indicating its use for dry eyes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.